Skip to content
Foreign Affairs Trade, International News

Top Innovators Compete in Taipei as ‘Go Healthy with Taiwan’ Finals Spotlight Health-Tech Advances

Taiwan Trade Centre Sydney 3 mins read

Six teams from around the world converged in Taipei on December 10, 2025, for the global finals of the “Go Healthy with Taiwan” Call for Proposals, culminating in the selection of three winning innovations poised to shape the future of global health. The competition—one of Taiwan’s flagship international innovation initiatives—attracted 638 proposals from 55 countries, underscoring Taiwan’s rising prominence as a hub for health technology and cross-border collaboration.

The top honours were awarded to teams from the United States, Ukraine, and Switzerland, whose proposals introduced cutting-edge solutions in smart healthcare, cycling innovation, and integrated sports technology. Each winning team received an “Infinite Taiwan”–themed trophy and USD 30,000 in prize funding.

A Global Platform for Health Innovation

At the awards ceremony, Susan Chi-Chuan Hu, Deputy Director General of the International Trade Administration (MOEA), emphasised the campaign’s global significance. She remarked, “Go Healthy with Taiwan is not only a call for proposals; it is a global journey that connects creativity and drives the health industry forward. Taiwan’s industrial strengths continue to attract worldwide participation, bringing us closer to the shared vision of building a healthier future together.” Hu reiterated the government’s commitment to fostering innovation, strengthening resilience and sustainability in the health sector, and creating an environment that supports global partnerships.

Six Finalists Reflect Global Health Priorities

The six finalist proposals addressed a wide range of pressing global challenges—from maternal health and sports technology to sustainable medical systems.

Finalist Highlights:

  • United States: Smart-textile motion data collection enhancing athletic safety and performance
  • Ukraine: Health system continuity amid geopolitical disruption
  • Switzerland: Sustainable healthcare technologies focused on energy efficiency and environmental impact

The winning proposals were recognised for their creativity, scalability, and cross-sector integration—key qualities that align with Taiwan’s long-term strategy to strengthen its position in the global health ecosystem.

Joe Chou, Executive Vice President of the Taiwan External Trade Development Council (TAITRA), praised the international competitiveness demonstrated by all finalists. He affirmed that Taiwan will continue serving as a global connector—linking innovators, industries, and markets to accelerate the worldwide adoption of Taiwan’s health technologies.

This year’s finals, themed “Outstanding Proposals! Racing Toward the Finish Line!”, brought together leaders from government, industry, and academia. Representatives from major associations—including Robert Wu, Chairman of the Taiwan Bicycle Association, and Yung-Chuan Li, Chairman of the Taiwan Medical and Biotech Industry Association—joined ambassadors and foreign dignitaries in Taiwan to celebrate the achievements.

Next Steps: Driving Global Impact

The International Trade Administration expressed hope that the finalists will deepen partnerships with Taiwanese companies and bring their solutions to market through international collaboration. As a long-term initiative, “Go Healthy with Taiwan” aims to build a global innovation platform, strengthen commercial opportunities, and inspire new models for collaborative health development worldwide.

For more information, please visit the official campaign website at gohealthy.taiwanexcellence.org.

About Taiwan Excellence

Taiwan Excellence Awards were launched by the Ministry of Economic Affairs (MOEA), Taiwan, R.O.C. in 1993. All products carrying this symbol have been selected for specific Taiwan Excellence Awards based on their excellence in R&D, design, quality, and marketing through a rigorous selection process.Therefore, they symbolize exquisite, innovative Taiwanese products. Selected by the government, the award-winning entries represent the epitome of Taiwanese industrial prowess and the perfect image of excellent product quality. The Taiwan Excellence symbol is recognized worldwide as it is trademarked and promoted in 106 countries and regions. www.taiwanexcellence.org for more information.

 

About Organisers

International Trade Administration (TITA), established by Taiwan's Ministry of Economic Affairs, is entrusted with planning trade policies, engaging in international cooperation, and promoting economic agreements. Responsibilities include trade barrier removal, data analysis, import-export administration, and addressing trade disputes. The Administration's comprehensive role spans trade promotion, MICE industry development, and managing commodity classification. It conducts investigations on import relief and anti-dumping cases, addressing diverse facets of international trade, making it a pivotal entity in Taiwan's global economic engagement. https://www.trade.gov.tw/English/

 


Taiwan External Trade Development Council (TAITRA) is the leading non-profit, semi-governmental trade promotion organization in Taiwan. It was founded in 1970 with the aim of promoting foreign trade, and is jointly sponsored by the government, industry associations, and several commercial organizations. The organization has a well-coordinated trade promotion and information network, which consists of over 1,200 trained specialists stationed throughout its Taipei headquarters and 60 branches worldwide. In conjunction with its sister organizations, the Taiwan Trade Center (TTC) and Taipei World Trade Center (TWTC), TAITRA has created a wealth of trade opportunities through effective promotion strategies. Please visit www.taitra.org.tw

 

Media

More from this category

  • International News, Political
  • 09/02/2026
  • 11:17
Monash University

Monash expert: Japan election

Japan’s prime minister, Sanae Takaichi’s Liberal Democratic Party and its coalition party are on track to hold a two-thirds majority in Japan’s lower house. A Monash expert is available to talk about the election win and the implications for Japan and the wider region. Available to comment: Associate Professor Charles Crabtree, Senior Lecturer, School of Social Sciences, Faculty of Arts Contact: +1 720 236 0778 or [email protected] The following comments can be attributed to Senior Lecturer Crabtree: “Takaichi’s electoral gamble has paid off, delivering her and the Liberal Democratic Party a supermajority in the House of Representatives. Her landslide victory…

  • International News
  • 06/02/2026
  • 17:00
NIPPON EXPRESS HOLDINGS, INC.

NIPPON EXPRESS HOLDINGS Obtains Minority Stake in Pakistan’s TCS Logistics (Private) Limited

TOKYO, Feb. 6, 2026 /Kyodo JBN/ -- NIPPONEXPRESS HOLDINGS, INC. announced that it has acquired a minority stake in TCS Logistics (Private) Limited (hereinafter "TCSL"), a logistics company primarily engaged in providing domestic logistics services in Pakistan, through its subsidiary NX South Asia & Oceania Co., Ltd. The acquisition took place on Monday, February 2, 2026. Logo: https://drive.google.com/file/d/1dqm0cxpYamnvMUra1AGXMuGlX932Z353/view?usp=drive_link Photo: https://drive.google.com/file/d/1YnnuMQ4QhY-f8Hpi9r5O-tf_Cq34QwSK/view?usp=drive_link The NX Group positions the provision of end-to-end solutions covering the entire customer supply chain as a key strategy for accelerating business growth in the global market, with a particular focus on strengthening global logistics capabilities in South Asia and…

  • Biotechnology, Foreign Affairs Trade
  • 30/01/2026
  • 06:00
Medicines Development for Global Health

Australian-developed treatment targets devastating leprosy reaction in global trial

Patients across Southeast Asia, Africa, and the United States will be among the first in the world to trial a new Australian-developed treatment for a devastating reaction to leprosy, offering the potential for life-changing care without the severe side effects of existing therapies. Announced on World Neglected Tropical Disease Day, the trial involving leprosy type 2 reaction patients will occur in the Philippines, Indonesia, Benin,Côte d'Ivoire, Madagascar and the United States. The tablet to be trialled is Dovramilast which is developed by Melbourne-based not-for-profit pharmaceutical company Medicines Development for Global Health (MDGH). Leprosy type 2 reaction is a debilitating inflammatory…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.